LUCC-Clinical Trials and Diagnostics Meeting

3 June 2026

13:00 - 16:00

Lund - BMC - A: Segerfalksalen

 

 

 

 

On the agenda:
 
  • Welcome (Lao Saal, Mats Jerkeman)
  • Speakers
    • Niklas Landberg (SUS/LU) - Targeting SLAMF6 in acute myeloid leukemia
    • Niklas Loman (SUS/LU) - NordicTrip randomized phase III trial in triple-negative breast cancer
    • Ingrid Teige (BioInvent) - BI-1808, a TNFR2 blocker/depleter, for T cell lymphoma
    • Lao Saal (LU) - NeoCircle prospective breast cancer ctDNA observational study
    • Karin Jirström (SUS/LU) - BILLIONSTARS prospective bile duct and liver cancer observational study
  • Discussion of future LUCC-CTaD activities

 

Lots of time for discussions.

 

Coffee/tea and fika will be served.

 

 

1.
For our planning purposes, please enter your email address below to indicate your attendance on June 3:
Invalid e-mail address
2.
If applicable, please indicate any allergies or dietary preferences: